Montpellier, France

Cynthia Sanchez

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cynthia Sanchez: Innovator in Cancer Diagnostics

Introduction

Cynthia Sanchez is a prominent inventor based in Montpellier, France. She has made significant contributions to the field of cancer diagnostics through her innovative research and patented methods. Her work focuses on the detection and treatment of cancer, utilizing advanced techniques to improve patient outcomes.

Latest Patents

Cynthia Sanchez holds a patent for a method for screening and treating a subject for cancer. This invention relates to the diagnostic evaluation of cancerous subjects. The method involves using Q-PCR based techniques and sequencing methods to quantify specific single-stranded DNA fragments obtained from cell-free nucleic acids (cfDNA). The research indicates that the levels of these DNA fragments differ significantly between healthy individuals and those with cancer. By analyzing the size distribution of these fragments, the method provides a reliable screening test for determining the presence of cancer in individuals.

Career Highlights

Throughout her career, Cynthia has worked with esteemed institutions such as the National Institute of Health and Medical Research (Institut National De La Santé et de La Recherche Médicale) and the University of Montpellier. Her dedication to advancing cancer research has positioned her as a key figure in the scientific community.

Collaborations

Cynthia has collaborated with various professionals in her field, including her coworker Alain Thierry. Their joint efforts have contributed to the development of innovative solutions in cancer diagnostics.

Conclusion

Cynthia Sanchez's work exemplifies the impact of innovation in the medical field, particularly in cancer diagnostics. Her patented methods offer promising advancements that could lead to earlier detection and better treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…